Abstract

Objectives: To evaluate the effect of thrombus aspiration (TA) strategy on the outcomes and its interaction with D-dimer levels in patients with ST-segment elevation myocardial infarction (STEMI) during primary percutaneous coronary intervention (PCI) in “real-world” settings.Materials and Methods: This study included 1,295 patients with STEMI who had undergone primary PCI with or without TA between January 2013 and June 2017. Patients were first divided into a TA+PCI group and a PCI-only group, and the baseline characteristics and long-term mortality between the two groups were analyzed. Furthermore, we studied the effect of TA on the clinical outcomes of patients grouped according to quartiles of respective D-dimer levels. The primary outcome was all-cause mortality, and the secondary outcomes were new-onset heart failure (HF), rehospitalization, re-PCI, and stroke.Results: In the original cohort, there were no significant differences in all-cause mortality between the TA+PCI and PCI-only groups (hazard ratio, 0.789; 95% confidence interval, 0.556–1.120; p = 0.185). After a mean follow-up of 2.5 years, the all-cause mortality rates of patients in the TA + PCI and PCI-only groups were 8.5 and 16.2%, respectively. Additionally, differences between the two groups in terms of the risk of HF, re-PCI, rehospitalization, and stroke were non-significant. However, after dividing into quartiles, as the D-dimer levels increased, the all-cause mortality rate in the PCI group gradually increased (4.3 vs. 6.0 vs. 7.0 vs. 14.7%, p < 0.001), while the death rate in the TA+PCI group did not significantly differ (4.6 vs. 5.0 vs. 4.0 vs. 3.75%, p = 0.85). Besides, in the quartile 3 (Q3) and quartile 4 (Q4) groups, the PCI-only group was associated with a higher risk of all-cause mortality than that of the TA+PCI group (Q3: 4.0 vs. 7.0%, p = 0.029; Q4: 3.75 vs. 14.7%, p < 0.001). Moreover, the multivariate logistic regression analysis demonstrated that TA is inversely associated with the primary outcome in the Q4 group [odds ratio (OR), 0.395; 95% CI, 0.164–0.949; p = 0.038].Conclusions: The findings of our real-world study express that routine manual TA during PCI in STEMI did not improve clinical outcomes overall. However, patients with STEMI with a higher concentration of D-dimer might benefit from the use of TA during primary PCI. Large-scale studies are recommended to confirm the efficacy of TA.

Highlights

  • Prompt reperfusion therapy has been recommended as the first and best treatment in patients with acute ST-segment elevation myocardial infarction (STEMI) [1, 2]

  • Patients in the percutaneous coronary intervention (PCI)-only group were more likely to have multivessel disease and less likely to have a stent implantation, and the culprit artery was more frequently the proximal left anterior descending artery compared with patients in the thrombus aspiration (TA)+PCI group

  • TA, thrombus aspiration; PCI, percutaneous coronary intervention; MI, myocardial infarction; CK-MB, creatine kinase isoenzyme MB; BNP, brain natriuretic peptide; LDLC, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; angiotensin-converting enzyme inhibitor (ACEI), angiotensin-converting–enzyme inhibitors; angiotensin-II receptor blocker (ARB), angiotensin-II–receptor blockers; IABP, intra-aortic balloon pump; LAD, left anterior descending. *Values were obtained by multivariate analysis after adjustment for age, gender, stent, thrombus aspiration, multivessel disease, medical therapy of aspirin, ACEI, βblocker, spironolactone, laboratory data of lactic acid (Lac), brain natriuretic peptide (BNP), creatinine (Cr), ejection fraction (LVEF), history of smoking and diabetes mellitus (DM)

Read more

Summary

Introduction

Prompt reperfusion therapy has been recommended as the first and best treatment in patients with acute ST-segment elevation myocardial infarction (STEMI) [1, 2]. Recent major clinical randomized controlled trials (TASTE and TOTAL trials) have challenged the clinical benefits of TA and do not support the routine use of manual TA in patients with STEMI requiring primary PCI [9, 10]. Due to such conflicting results, the routine use of TA during primary PCI is not recommended [1]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call